Data resource profile: the national health information database of the National Health Insurance Service in South Korea

S Cheol Seong, YY Kim, YH Khang… - International journal …, 2017 - academic.oup.com
Data resource basics: The National Health Information Database (NHID) is a public
database on health care utilization, health screening, socio-demographic variables, and …

Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone

JH Kang, SI Lee, DH Lim, KW Park, SY Oh… - Journal of Clinical …, 2012 - ascopubs.org
Purpose When designing this trial, there was no evidence that salvage chemotherapy (SLC)
in advanced gastric cancer (AGC) resulted in substantial prolongation of survival when …

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

J Lee, SH Park, HM Chang, JS Kim, HJ Choi… - The lancet …, 2012 - thelancet.com
Background Combination chemotherapy with gemcitabine and a platinum-based agent is
regarded as a standard treatment for patients with advanced biliary-tract cancer. Results of …

Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study

S Park, CM Oh, H Cho, JY Lee, KW Jung, JK Jun… - bmj, 2016 - bmj.com
Objective To investigate whether screening for thyroid cancer led to the current “epidemic” in
South Korea. Design Review of the medical records of nationally representative samples of …

[HTML][HTML] Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010

KW Jung, YJ Won, HJ Kong, CM Oh… - … : official journal of …, 2013 - synapse.koreamed.org
Purpose This article gives an overview of nationwide cancer statistics, including incidence,
mortality, survival and prevalence, and their trends in Korea based on 2010 cancer …

[HTML][HTML] Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized …

ST Kim, JH Kang, J Lee, HW Lee, SY Oh, JS Jang… - Annals of …, 2019 - Elsevier
Background Capecitabine plus oxaliplatin (XELOX) has shown modest activity and tolerable
toxicity in a phase II trial for biliary tract cancers (BTCs). Meanwhile, gemcitabine plus …

[HTML][HTML] Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009

KW Jung, S Park, HJ Kong, YJ Won… - … : official journal of …, 2012 - synapse.koreamed.org
Purpose This study overviews nationwide cancer statistics, including incidence, mortality,
survival, and prevalence, and their trends in Korea based on 2009 cancer incidence data …

Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer

DW Shin, J Cho, SY Kim, E Guallar, SS Hwang… - Annals of surgical …, 2013 - Springer
Background Surgery for cancer is often delayed due to variety of patient-, provider-, and
health system–related factors. However, impact of delayed surgery is not clear, and may …

Performance of different gastric cancer screening methods in Korea: a population-based study

KS Choi, JK Jun, EC Park, S Park, KW Jung, MA Han… - PLoS …, 2012 - journals.plos.org
Background There is a lack of agreement on which gastric cancer screening method is the
most effective in the general population. The present study compared the relative …

Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells

SH Kim, GS Choo, ES Yoo, JS Woo… - Oncology …, 2019 - spandidos-publications.com
Apoptosis is regarded as a therapeutic target because it is typically disturbed in human
cancer. Silymarin from milk thistle (Silybum marianum) has been reported to exhibit …